logo
Search…
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Home > Latest

Lates News

date
03/05/2025
Jefferies Investment Bank: Downgrade Arvinas (ARVN.US) rating from Buy to Hold, target price adjusted from $52.00 to $10.00.
Latest
5 m ago
UBS: Maintains Aptiv (APTV.US) rating, adjusted from Neutral to Neutral rating, target price adjusted from $58.00 to $66.00.
6 m ago
UBS: Maintains neutral rating on Howmet Aerospace (HWM.US), with target price adjusted from 120.00 US dollars to 155.00 US dollars.
9 m ago
UBS: Maintains a buy rating on Amicus Therapeutics (FOLD.US), adjusted from a buy to a buy rating, with a target price adjusted from $21.00 to $22.00.
11 m ago
Credit Suisse: Maintains rating for Estee Lauder Cos (EL.US) at Neutral, adjusts target price from $60.00 to $62.00.
12 m ago
UBS: Maintains rating on Cardinal Health (CAH.US) at Buy, adjusted from Buy to Buy rating, with a target price adjusted from $160.00 to $170.00.
See all latestmore
logo
Contact US
qr
+852 - 60190728
gmteight@futurecultural.com
Customer Support
About Us
Contact Us
Frequently Asked
Privacy Policy
Terms of Use
Commercial Services
Advertising
Business Development
Copyright
Terms of Service
©️2013 - 2025 GMT EIGHT Holdings. All Rights Reserved.